Barrington Research Reaffirms “Outperform” Rating for Henry Schein (NASDAQ:HSIC)

Henry Schein (NASDAQ:HSIC)‘s stock had its “outperform” rating reiterated by investment analysts at Barrington Research in a report released on Friday, Benzinga reports. They currently have a $82.00 price target on the stock. Barrington Research’s price target suggests a potential upside of 14.83% from the company’s previous close.

Other equities analysts have also issued research reports about the company. Baird R W upgraded Henry Schein from a “hold” rating to a “strong-buy” rating in a research note on Monday, July 22nd. Robert W. Baird cut their target price on shares of Henry Schein from $92.00 to $82.00 and set an “outperform” rating on the stock in a research report on Wednesday, August 7th. Piper Sandler reaffirmed an “overweight” rating and issued a $86.00 price target on shares of Henry Schein in a research report on Friday, June 21st. JPMorgan Chase & Co. cut their price objective on shares of Henry Schein from $88.00 to $80.00 and set an “overweight” rating on the stock in a report on Monday, August 12th. Finally, UBS Group reduced their price objective on shares of Henry Schein from $75.00 to $72.00 and set a “neutral” rating for the company in a research note on Wednesday, August 7th. One analyst has rated the stock with a sell rating, six have assigned a hold rating, five have assigned a buy rating and one has assigned a strong buy rating to the stock. According to data from MarketBeat, Henry Schein presently has an average rating of “Hold” and a consensus target price of $77.10.

Henry Schein Trading Down 1.6 %

Henry Schein stock traded down $1.13 during trading hours on Friday, hitting $71.41. The company had a trading volume of 153,945 shares, compared to its average volume of 1,323,032. The company has a debt-to-equity ratio of 0.46, a quick ratio of 0.90 and a current ratio of 1.55. The firm has a market cap of $9.14 billion, a P/E ratio of 24.13, a P/E/G ratio of 1.88 and a beta of 0.86. The company has a 50-day moving average price of $69.77 and a two-hundred day moving average price of $70.42. Henry Schein has a 1 year low of $60.01 and a 1 year high of $82.63.

Henry Schein (NASDAQ:HSIC) last announced its quarterly earnings results on Tuesday, August 6th. The company reported $1.23 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.22 by $0.01. Henry Schein had a return on equity of 13.19% and a net margin of 2.82%. The firm had revenue of $3.10 billion during the quarter, compared to analyst estimates of $3.27 billion. During the same quarter in the previous year, the business earned $1.31 earnings per share. Henry Schein’s quarterly revenue was up .0% on a year-over-year basis. On average, sell-side analysts anticipate that Henry Schein will post 4.75 earnings per share for the current year.

Insider Buying and Selling

In other Henry Schein news, SVP Lorelei Mcglynn sold 21,035 shares of the firm’s stock in a transaction on Friday, September 6th. The shares were sold at an average price of $69.30, for a total value of $1,457,725.50. Following the completion of the transaction, the senior vice president now owns 71,833 shares of the company’s stock, valued at $4,978,026.90. The transaction was disclosed in a filing with the SEC, which is available at this link. 1.14% of the stock is owned by company insiders.

Institutional Investors Weigh In On Henry Schein

Several hedge funds have recently bought and sold shares of the stock. Vanguard Group Inc. lifted its stake in shares of Henry Schein by 1.7% in the 1st quarter. Vanguard Group Inc. now owns 15,432,001 shares of the company’s stock valued at $1,165,425,000 after purchasing an additional 260,537 shares during the period. American Century Companies Inc. increased its holdings in Henry Schein by 3.1% in the second quarter. American Century Companies Inc. now owns 5,484,286 shares of the company’s stock valued at $351,543,000 after buying an additional 162,477 shares in the last quarter. Swedbank AB acquired a new position in shares of Henry Schein in the first quarter worth about $215,998,000. Fiduciary Management Inc. WI boosted its stake in shares of Henry Schein by 17.1% during the 4th quarter. Fiduciary Management Inc. WI now owns 2,284,337 shares of the company’s stock worth $172,947,000 after acquiring an additional 333,855 shares in the last quarter. Finally, Nuance Investments LLC grew its position in shares of Henry Schein by 6.2% during the 2nd quarter. Nuance Investments LLC now owns 1,863,333 shares of the company’s stock valued at $119,440,000 after acquiring an additional 108,143 shares during the period. Hedge funds and other institutional investors own 96.62% of the company’s stock.

About Henry Schein

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.